76-18-214. Unlawful use of a license number in the course of manufacturing or distributing a controlled substance.
327 words·~1 min read·
/ut/title-76/chapter-18/76-18-214A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Effective 5/6/2026
76-18-214. Unlawful use of a license number in the course of manufacturing or distributing a controlled substance.
(1)Terms defined in Sections 58-37-101 , 76-1-101.5 , 76-18-101 , and 76-18-201 apply to this section.
(2)An actor commits unlawful use of a license number in the course of manufacturing or distributing a controlled substance if the actor knowingly and intentionally uses, in the course of the manufacture or distribution of a controlled substance, a license number that is fictitious, revoked, suspended, or issued to another person.
(3)A violation of Subsection
(2)is:
(a)a class A misdemeanor on a first or second conviction; or
(b)a third degree felony on a third or subsequent conviction.
(a)An actor may be charged and sentenced for a violation of this section, notwithstanding a charge and sentence for a violation of any other section of this part or Title 58, Chapter 37, Controlled Substances.
(b)A penalty imposed for a violation of this section is in addition to, and not in lieu of, a civil or administrative penalty or sanction authorized by law.
(c)Defenses and exemptions in Section 76-18-203 apply to this section.
(d)A previous conviction used for a penalty enhancement under this section includes a conviction for an offense described in a statute previously in effect in this state that is the same or substantially similar to a violation of this section.
(5)If a minor who is under 18 years old is found by a court to have violated this section, the court may order the minor to complete:
(a)a screening as defined in Section 41-6a-501 ;
(b)an assessment as defined in Section 41-6a-501 if the screening described in Subsection (5)(a) indicates that an assessment is appropriate; and
(c)an educational series as defined in Section 41-6a-501 or substance use disorder treatment as indicated by an assessment described in Subsection (5)(b) .
Enacted by Chapter 362 , 2026 General Session